• Recent
  • Class
  • Inventors
  • Assignees
  • Top Lists
  • Pricing
  • Account
Patents-Review.com
  1. Home
  2. Inventor
  3. B
  4. Bod…
  5. Bodson Guy
🔗 Permalink
Inventor profile of:

Guy Bodson

City:

Bellefontaine

Country:

Belgium

Published Applications:

5

Last publication date:

2007-06-21

Recent patent applications by Bodson Guy

Guy Bodson from Bellefontaine, BE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2007-06-21
US20070142400A1
Human necessities

Enantjomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine

#2 | 2006-11-09
US20060252934A1
Human necessities

Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl]piperazine

#3 | 2006-10-12
US20060229319A1
Human necessities

Enantiomers of 1-[(4-chlorophenyl) phenylmethyl)-4-[(4-methylphenyl)sulfonyl] piperazine

#4 | 2005-08-18
US20050182069A1
Human necessities

Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine

#5 | 2005-08-11
US20050176732A1
Human necessities

Enantiomers of 1-(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine

InventorID:

4436951 ⎘

  1. Home
  2. Inventor
  3. B
  4. Bod…
  5. Bodson Guy

Some parts © 2022-2026 Patents-Review.com

Browse & Discovery
  • Home
  • Patent Classification
  • Inventor Index
  • Assignee Index
  • Interesting Applications
Search & Tools
  • Basic Search
  • Advanced Search
  • Patent Alerts
  • Top Lists
  • Statistics
Information & Resources
  • About US Patent System
  • Terms & Privacy
  • Pricing
  • Contact
Quick Access
  • Latest Applications
  • Top Inventors 2026
  • Top Assignees 2026
  • Featured Patents
Disclaimer: This website is intended for informational purposes only, and its content is based on public patent records. Please note that some sections of this website have been created or processed using machine learning models. We provide content in good faith but make no guarantees regarding accuracy or completeness. By using this site, you accept any risks and waive claims against us for errors or omissions.